Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effects of unfractionated heparin, dermatan sulfate and low molecular weight heparin on vessel wall permeability in rabbits.

× No keyword cloud information.

11 in total

Review 1. Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors: David A Garcia; Trevor P Baglin; Jeffrey I Weitz; Meyer Michel Samama
Journal: Chest Date: 2012-02 Impact factor: 9.410

2. Vascular glycosaminoglycans in periventricular leukoencephalopathy.

Authors: R M Torack; J C Morris
Journal: Acta Neuropathol Date: 1989 Impact factor: 17.088

Review 3. Anticoagulation therapy in children.

Authors: Milind D Ronghe; Christina Halsey; Nicholas J Goulden
Journal: Paediatr Drugs Date: 2003 Impact factor: 3.022

4. Mesoglycan: clinical evidences for use in vascular diseases.

Authors: Antonella Tufano; Claudia Arturo; Ernesto Cimino; Matteo Nicola Dario Di Minno; Mirko Di Capua; Anna Maria Cerbone; Giovanni Di Minno
Journal: Int J Vasc Med Date: 2010-08-31

5. Prophylactic Low Molecular Weight Heparin Improving Perinatal Outcome in Non-thrombophilic Placental-Mediated Complications.

Authors: Shweta Singh; Renuka Sinha; Mayank Kaushik
Journal: J Obstet Gynaecol India Date: 2015-07-09

10. Heparin inhibits NF-kappaB activation and increases cell death in cerebral endothelial cells after oxygen-glucose deprivation.

Authors: Jeong Ho Lee; Jinu Lee; Gi Ho Seo; Chul Hoon Kim; Young Soo Ahn
Journal: J Mol Neurosci Date: 2007 Impact factor: 2.866

Effects of unfractionated heparin, dermatan sulfate and low molecular weight heparin on vessel wall permeability in rabbits.

Review 1. Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

2. Vascular glycosaminoglycans in periventricular leukoencephalopathy.

Review 3. Anticoagulation therapy in children.

4. Mesoglycan: clinical evidences for use in vascular diseases.

5. Prophylactic Low Molecular Weight Heparin Improving Perinatal Outcome in Non-thrombophilic Placental-Mediated Complications.

Review 6. Heparin therapy. Regimens and treatment considerations.

7. Intestinal absorption of fucoidan extracted from the brown seaweed, Cladosiphon okamuranus.

Review 8. The prevention and treatment of venous thromboembolism with LMWHs and new anticoagulants.

9. The antineoplastic effect of low-molecular-weight heparins - a literature review.

10. Heparin inhibits NF-kappaB activation and increases cell death in cerebral endothelial cells after oxygen-glucose deprivation.